MedTrace Logo

Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery

NCT03702400 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2021-04-13

No results posted yet for this study

Summary

This study evaluate the ability of phenylephrine and of noradrenaline to maintain normal systemic arterial blood pressure and heart rate in healthy pregnant women submitted to cesarean section with spinal anesthesia. Half of participants will receive bolus of phenylephrine while the other half will receive bolus of noradrenaline.

Conditions

Interventions

DRUG

Phenylephrine 100 mcg

Phenylephrine at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug, 5 mL each bolus

DRUG

Norepinephrine 5 mcg

Norepinephrine at a dose of 5 mcg at dilution containing 1 mcg / mL, 5 mL each bolus

Sponsors & Collaborators

  • Hospital dos Servidores do Estado do Rio de Janeiro

    lead OTHER_GOV

Principal Investigators

  • DANIEL V DE QUEIROZ · HOSPITAL FEDERAL DOS SERVIDORES DO ESTADO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-06-01
Completion
2020-10-01
FDA Drug
Yes

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03702400 on ClinicalTrials.gov